Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date01 Jul 1962 |
100 Clinical Results associated with Suzu Funmatsu Yakuhin K.K.
0 Patents (Medical) associated with Suzu Funmatsu Yakuhin K.K.
100 Deals associated with Suzu Funmatsu Yakuhin K.K.
100 Translational Medicine associated with Suzu Funmatsu Yakuhin K.K.